Details for New Drug Application (NDA): 217409
✉ Email this page to a colleague
The generic ingredient in PIPERACILLIN AND TAZOBACTAM is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 217409
Tradename: | PIPERACILLIN AND TAZOBACTAM |
Applicant: | Eugia Pharma |
Ingredient: | piperacillin sodium; tazobactam sodium |
Patents: | 0 |
Pharmacology for NDA: 217409
Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 217409
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 217409 | ANDA | Eugia US LLC | 55150-473 | 55150-473-01 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-473-01) / 152 mL in 1 VIAL, PHARMACY BULK PACKAGE |
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 217409 | ANDA | Eugia US LLC | 55150-474 | 55150-474-01 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-474-01) / 51 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | ||||
Approval Date: | Oct 12, 2023 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | ||||
Approval Date: | Oct 12, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription